CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Abbott Laboratories Company Snapshot
Abbott Laboratories operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abbott Laboratories with three other companies in this sector in UNITED STATES : Bristol-Myers Squibb Company (2020 sales of $42.52 billion of which 28% was Prioritized Brands-Revlimid), Eli Lilly and Company ($24.54 billion of which 29% was Oncology-Verzenio & Other), and Pfizer Inc. ($41.91 billion of which 26% was Oncology).

Sales Analysis. During the second quarter of 2021, sales at Abbott Laboratories totalled $10.22 billion. This is an increase of 39.5% from the $7.33 billion in sales at the company during the second quarter of 2020. This was the largest same quarter increase in sales since the fourth quarter of 2017. During the first two quarters of 2021, sales totalled $20.68 billion, which is 37.4% higher than through the first two quarters of 2020. During the year ended December of 2020, sales at Abbott Laboratories were $34.61 billion. This is an increase of 8.5% versus 2019, when the company's sales were $31.90 billion. This was the fifth consecutive year of sales increases at Abbott Laboratories (and since 2015, sales have increased a total of 70%). Sales of Diagnostics Products saw an increase that was more than double the company's growth rate: sales were up 40.1% in 2020, from $7.71 billion to $10.81 billion. Abbott Laboratories also saw significant increases in sales in Other (up 15.8% to $66.00 million) . Not all segments of Abbott Laboratories experienced an increase in sales in 2020: sales of Established Pharmaceutical Products fell 4.1% to $4.30 billion. Abbott Laboratories also experienced decreases in sales in Medical Devices (down 3.7% to $11.79 billion) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Abbott Laboratories
  Stock Performance Chart for Abbott Laboratories
 
  Stock Data: Recent Stock Performance:
  Current Price (10/15/2021): 117.49
(Figures in U.S. Dollars)
1 Week -0.8%   13 Weeks -7.3%  
4 Weeks 0.0%   52 Weeks 7.1%  
 
Abbott Laboratories Key Data:
  Ticker: ABT Country: United States
  Exchanges: NYSE FRA LON MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 34,608,000,000
(Year Ending Jan 2021).
Employees: 109,000
  Currency: U.S. Dollars Market Cap: 208,288,310,334
  Fiscal Yr Ends: December Shares Outstanding: 1,772,817,349
  Share Type: Common Closely Held Shares: 12,955,163
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.